• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Genome Sequencing in the Setting of Fetal Structural Anomalies

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Wang et al. (Prenatal Diagnosis, 2022) investigated the potential of genome sequencing as a single comprehensive prenatal test when fetal abnormalities are detected on ultrasound

METHODS:

  • Prospective cohort study
  • Participants
    • Singleton fetuses
    • Ultrasound-identified structural abnormalities | At least one finding was not a soft marker 
    • Undergoing invasive prenatal testing
  • Exposures
    • Genome sequencing, in parallel with standard diagnostic testing
  • Study design
    • Genetic variants were classified according to ACMG guidelines and reviewed by a panel of board-certified laboratory and clinical geneticists
  • Primary outcome
    • Clinical sensitivity of genome sequencing

RESULTS:

  • 37 fetuses received genome sequencing
  • Routine diagnostic testing included
    • Rapid Aneuploidy Detection (RAD) by QF-PCR
    • Microarray analysis
    • DNA sequencing using gene panels or exome sequencing if indicated
  • Diagnostic sequence variants identified: 14% of population (in 5 fetuses)
  • Variants of uncertain significance found: 19% of population (in 7 fetuses)
  • Genome sequencing also identified the 2 CNVs (5% of cases) reported by clinical microarray including

CONCLUSION:

  • Genome sequencing identified all pathogenic variants reported by clinical microarray and exome sequencing
  • Genome sequencing in this population achieved a diagnostic yield of 19% (5 sequence variants and 2 copy number variants)
  • Variants of uncertain significance were identified in a further 19% of fetuses, which may explain structural anomalies observed
  • The authors state

In conclusion, this study provides further evidence that GS has the potential to replace multiple consecutive tests, including microarray, gene panels, and ES, to provide the most comprehensive genetic analysis rapidly

Learn More – Primary Sources:

Diagnostic yield of genome sequencing for prenatal diagnosis of fetal structural anomalies

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Can we Sequence an Entire Fetal Genome from an Amniocentesis Sample?
Does Prenatal Exome Sequencing Have a Role in Fetuses with Isolated Increased Nuchal Translucency?
Ultra-Rapid Exome Sequencing in Critically Ill Neonatal and Pediatric Patients

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site